Metabolic Recovery of the Failing Heart: Emerging Therapeutic Options.

about

Metabolic Recovery of the Failing Heart: Emerging Therapeutic Options.

Item

http://www.wikidata.org/entity/Q39245449

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Metabolic Recovery of the Failing Heart: Emerging Therapeutic Options.

@en

Metabolic Recovery of the Failing Heart: Emerging Therapeutic Options.

@nl

type

Item

label

Metabolic Recovery of the Failing Heart: Emerging Therapeutic Options.

@en

Metabolic Recovery of the Failing Heart: Emerging Therapeutic Options.

@nl

prefLabel

Metabolic Recovery of the Failing Heart: Emerging Therapeutic Options.

@en

Metabolic Recovery of the Failing Heart: Emerging Therapeutic Options.

@nl

P1476

Metabolic Recovery of the Failing Heart: Emerging Therapeutic Options

@en

P2093

Dale J Hamilton

http://www.w3.org/2001/XMLSchema#string

P2860

The Use of SGLT-2 Inhibitors in Type 2 Diabetes and Heart Failure

Targeting mitochondrial cardiolipin and the cytochrome c/cardiolipin complex to promote electron transport and optimize mitochondrial ATP synthesis

Noninvasive Detection of Early Metabolic Left Ventricular Remodeling in Systemic Hypertension.

Ipragliflozin and other sodium-glucose cotransporter-2 (SGLT2) inhibitors in the treatment of type 2 diabetes: preclinical and clinical data.

Reduction of early reperfusion injury with the mitochondria-targeting peptide bendavia

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.

Glucagon-like peptide-1 increases myocardial glucose uptake via p38alpha MAP kinase-mediated, nitric oxide-dependent mechanisms in conscious dogs with dilated cardiomyopathy

Mechanical unloading promotes myocardial energy recovery in human heart failure.

Ranolazine reduces Ca2+ overload and oxidative stress and improves mitochondrial integrity to protect against ischemia reperfusion injury in isolated hearts

Cardioprotection Resulting from Glucagon-Like Peptide-1 Administration Involves Shifting Metabolic Substrate Utilization to Increase Energy Efficiency in the Rat Heart

P304

25-28

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.14797/MDCJ-13-1-25

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Dale J Hamilton

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28413579

http://www.w3.org/2001/XMLSchema#string

P932

5385791

http://www.w3.org/2001/XMLSchema#string